Vivekanandan Kalaiselvan
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 31
- Pharmacovigilance and Adverse Drug Reactions 29
-
- Pharmaceutical Economics and Policy 14
- Co-authors
- Gyanendra Nath Singh (13 shared papers)Prasad Thota (10 shared papers)Jai Prakash (1 shared paper)Shatrunajay Shukla (12 shared papers)Sushma Srivastava (2 shared papers)Suresh Kumar (1 shared paper)Priya Kashyap (1 shared paper)SK Gupta (2 shared papers)
- Journals
- Therapeutic Innovation & Regulatory Science (5 papers)Indian Journal of Pharmaceutical Education and Research (2 papers)Bulletin of the World Health Organization (2 papers)Drug Safety (2 papers)Expert Opinion on Drug Safety (2 papers)
- Partner nations
- IndiaUnited StatesBangladesh
In The Last Decade
Vivekanandan Kalaiselvan
67 papers receiving 625 citations
Peers
Comparison fields: 5 of 114
- Toxicology 293
- Medical Laboratory Technology 36
- Geriatrics and Gerontology 54
- Applied Microbiology and Biotechnology 26
- Pharmacology 117
Countries citing papers authored by Vivekanandan Kalaiselvan
This map shows the geographic impact of Vivekanandan Kalaiselvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivekanandan Kalaiselvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivekanandan Kalaiselvan more than expected).
Fields of papers citing papers by Vivekanandan Kalaiselvan
This network shows the impact of papers produced by Vivekanandan Kalaiselvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivekanandan Kalaiselvan. The network helps show where Vivekanandan Kalaiselvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vivekanandan Kalaiselvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 68 | |
| 2 | 2012 | 52 | |
| 3 | 2015 | 48 | |
| 4 | 2018 | 39 | |
| 5 | 2020 | 38 | |
| 6 | 2019 | 30 | |
| 7 | 2014 | 24 | |
| 8 | 2015 | 22 | |
| 9 | 2023 | 21 | |
| 10 | 2022 | 20 | |
| 11 | 2019 | 17 | |
| 12 | 2019 | 17 | |
| 13 | 2015 | 16 | |
| 14 | 2015 | 15 | |
| 15 | 2019 | 13 | |
| 16 | 2022 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2014 | 12 | |
| 19 | 2023 | 12 | |
| 20 | ASSESSMENT OF PREVALENCE OF POTENTIAL DRUG-DRUG INTERACTIONS IN MEDICAL INTENSIVE CARE UNIT OF A TERTIARY CARE HOSPITAL IN INDIA | 2014 | 9 |
About Vivekanandan Kalaiselvan
Vivekanandan Kalaiselvan is a scholar working on Toxicology, Economics and Econometrics, Computational Theory and Mathematics, Pharmacology and Public Health, Environmental and Occupational Health, having authored 75 papers that have together received 687 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (29 papers), Pharmaceutical Economics and Policy (14 papers), Computational Drug Discovery Methods (11 papers), Pharmaceutical Quality and Counterfeiting (7 papers), Quality and Safety in Healthcare (6 papers), Drug-Induced Adverse Reactions (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (5 papers). The work is most often cited by research in Toxicology (293 citations), Medical Laboratory Technology (36 citations), Geriatrics and Gerontology (54 citations), Applied Microbiology and Biotechnology (26 citations) and Pharmacology (117 citations). Vivekanandan Kalaiselvan has collaborated with scholars based in India, United States and Bangladesh. Frequent co-authors include Gyanendra Nath Singh, Prasad Thota, Jai Prakash, Shatrunajay Shukla, Sushma Srivastava, Suresh Kumar, Priya Kashyap, SK Gupta, Ritu Tiwari and Rajeev Singh Raghuvanshi. Their work appears in journals such as Therapeutic Innovation & Regulatory Science, Indian Journal of Pharmaceutical Education and Research, Bulletin of the World Health Organization, Drug Safety and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.